References
- American Psychiatric Association. DSM-IIIR. Manuale Diagnostico e Statistico dei Disturbi Mentali. Masson, Milano 19881. American Psychiatric Association. DSM-IIIR. Manuale Diagnostico e Statistico dei Disturbi Mentali. Masson, Milano 1988
- Arana G. W., Pearlman C., Shader R. I. Alprazolam induced mania: two clinical cases. Am. J. Psychiatry 1985; 142: 3682. Arana G. W., Pearlman C., Shader R. I. Alprazolam induced mania: two clinical cases. Am. J. Psychiatry 1985; 142: 368
- Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1960; 32: 503. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 1960; 32: 50
- Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 564. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56
- Itil T. M., Menon G. N., Itil K. Z. Computer EEG drug data base in psychopharmacology and in drug development. Psychopharmacol. Bull. 1982; 18: 45. Itil T. M., Menon G. N., Itil K. Z. Computer EEG drug data base in psychopharmacology and in drug development. Psychopharmacol. Bull. 1982; 18: 4
- von Knorring L. Morbidity risk for psychiatric disorders in relatives of patients with neurotic-reactive depression. “Anxious Depression”, G. Racagni, E. Smeraldi. Raven Press, New York 1987; 636. von Knorring L. Morbidity risk for psychiatric disorders in relatives of patients with neurotic-reactive depression. “Anxious Depression”, G. Racagni, E. Smeraldi. Raven Press, New York 1987; 63
- Post R. M., Uhde T. W. Clinical approaches to treatment–resistant bipolar illness. Am. Psychiatr. Assoc. Annu. Rev. 1986; 6: 1417. Post R. M., Uhde T. W. Clinical approaches to treatment–resistant bipolar illness. Am. Psychiatr. Assoc. Annu. Rev. 1986; 6: 141
- Rasmussen S., Sorensen T., Wildshiodtz G. Neurosis depressive, an efter-undersogelse. Nord. Psychiatr. Tidskr. 1978; 3218. Rasmussen S., Sorensen T., Wildshiodtz G. Neurosis depressive, an efter-undersogelse. Nord. Psychiatr. Tidskr. 1978; 321
- Saito M. Clinical significance and methodological discovery and the prediction of psychotropic properties of a newly developed substance. In: “Proceedings of the 10th Congress of the Collegium Internationale Neuropsychopharmacologicum, July 1976”. Neuropsycho-pharmacol 1978; 51: 11919. Saito M. Clinical significance and methodological discovery and the prediction of psychotropic properties of a newly developed substance. In: “Proceedings of the 10th Congress of the Collegium Internationale Neuropsychopharmacologicum, July 1976”. Neuropsycho-pharmacol 1978; 51: 1191
- Setoguchi M., Takehara S., Nakajima A., Tsumagari T., Takigawa Y. Effects of etizolam on the metabolism of biogenic amines in brain. Arzneim. Forsch. 1978; 28: 116510. Setoguchi M., Takehara S., Nakajima A., Tsumagari T., Takigawa Y. Effects of etizolam on the metabolism of biogenic amines in brain. Arzneim. Forsch. 1978; 28: 1165
- Shibata M. Etizolam: pharmacokinetics in humans and pharmacological actions of metabolites. Unpublished results. Yoshitomi, Japan 198811. Shibata M. Etizolam: pharmacokinetics in humans and pharmacological actions of metabolites. Unpublished results. Yoshitomi, Japan 1988
- Torgersen S. Developmental differentiation of anxiety and affective neuroses. Acta Psychiatr. Scand. 1985; 71: 30412. Torgersen S. Developmental differentiation of anxiety and affective neuroses. Acta Psychiatr. Scand. 1985; 71: 304